Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Completed · Not applicable

Conditions studied: Idiopathic Pulmonary Fibrosis

In brief

The purpose of this study is to determine the effects of Pulmonary Rehabilitation (PR) on shortness of breath, exercise capacity, symptom control, mental health, cognitive function, and quality of life in patients with Idiopathic Pulmonary Fibrosis (IPF). Pulmonary rehabilitation has already been shown to benefit patients with other chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD). We believe that pulmonary rehabilitation will benefit patients with IPF as well.

Key facts

Study ID

NCT00692796

Run by

National Jewish Health

People needed

60

Starts

2008-04-01

Expected to finish

2010-03-01

Last updated by the study team

2017-03-29

Who can join

Age: 40 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 40 years or older
• Diagnosis of IPF according to American Thoracic Society criteria

You may not qualify if…

• Patients who have completed a PR program within the last two years
• Patients with unstable medical conditions that would make PR unsafe

Where it is running

• National Jewish Medical and Research Center — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.